1. Pancreatic cancer;Mizrahi;Lancet,2020
2. Immune conversion of tumor microenvironment by oncolytic viruses: the protoparvovirus H-1PV case study;Marchini;Front Immunol,2019
3. Clinical landscape of oncolytic virus research in 2020;Macedo;J Immunother Cancer,2020
4. Oncolytic virus immunotherapy;Marchini;Cancers (Basel),2021
5. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis;Lanson;Cancer Res,2003